Quantcast
Last updated on April 17, 2014 at 14:35 EDT

Latest Omeprazole Stories

2011-11-17 08:00:00

DEERFIELD, Ill., Nov. 17, 2011 /PRNewswire/ -- Today, Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a study in healthy subjects demonstrating that DEXILANT had no clinically important effect on exposure to the active metabolite of clopidogrel or clopidogrel-induced platelet inhibition. No dose adjustment of clopidogrel is necessary when administered with an approved dose of DEXILANT. DEXILANT is...

2011-09-09 07:00:00

NEXIUM® Prescription Benefit cards now made available online at nexiumsupport.ca To view the Enriched Media Release, click here: http://smr.newswire.ca/en/sti/sti-enables-astrazeneca-to-allow-ongoing-choice-for HALIFAX, Sept. 9, 2011 /PRNewswire/ - Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in...

2011-08-10 08:00:00

SEATTLE, Aug. 10, 2011 /PRNewswire/ -- The following statement is being issued by GCG Inc., Notice Administrator regarding the Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Docket No. 05-0269. If You Purchased the Drug Nexium® (esomeprazole magnesium) in Massachusetts, A Class Action Lawsuit May Affect Your Rights. There is a class action lawsuit pending in Suffolk County Superior Court in the Commonwealth of Massachusetts ("Lawsuit"). The name of the...

2011-07-27 00:01:19

Horse Gold Unique Proprietary Formula Obliterates Gastric Pain in Horses Bradenton, FL (PRWEB) July 26, 2011 Horse Gold, makers of hyper-effective equine supplements created by horsemen for horsemen, officially released Gastromax3â“ž¢ paste, an affordable, once-a-day preventive anti-ulcer supplement for horses. Gastromax3â“ž¢ paste is formulated to prevent debilitating ulcers using omeprazole, a protein pump inhibitor that blocks the...

2011-05-18 00:17:45

In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA. "GERD is a highly prevalent disorder caused by the reflux of gastric contents into the esophagus. It is a chronic, relapsing disease that negatively affects...

2011-04-05 09:30:00

NEW ORLEANS, April 5, 2011 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than...

2011-01-19 13:38:00

RADNOR, Pa., Jan. 19, 2011 /PRNewswire/ -- HTH Worldwide, a global health and safety services company, today announced the expansion of its mobile and online brand name medication translation guide for world travelers. Prescription and over-the-counter drug names often vary by country -- for example Prilosec is called Lomac or Prilosid in India -- so those traveling, living or studying abroad need to be sure they are getting the precise equivalent of medications they were prescribed at...

2011-01-06 07:00:00

NEW YORK, Jan. 6, 2011 /PRNewswire/ -- The National Football League, Prilosec OTC® and Pro Football Hall of Fame Coach JOHN MADDEN today announced the start of fan voting at www.maddenprotectorsaward.com for the second annual Madden Most Valuable Protectors Award, presented by Prilosec OTC. The award honors the NFL's best offensive line for the 2010 NFL regular season. Fan voting, which lasts until Friday, January 21, serves as the final piece of the puzzle in...

2010-11-25 21:43:30

Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed. The original study found that on the basis of data from more than 840,000 live births in Denmark, there was no evidence to suggest that the use of the most common...

2010-11-09 22:30:00

NEW YORK, Nov. 9, 2010 /PRNewswire/ -- See Still Image from Cipla at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=7d84d552-15c1-4161-bc08-40a209cf6c99 Cipla, one of the world's leading generic pharmaceutical companies is the first from India to get The Australian Pesticides and Veterinary Medicines Authority (APVMA) approval for introducing its generic omeprazole in Australia used in treating equine ulcers. Introduced under the brand name E-Gard by Cipla, this premium...